News | February 01, 2023
Sun Pharma Q3 FY23 Gross Sales up 13.1%; Net profit up 5.2%
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
Zidavi is recommended by the Infectious Disease Society of America
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Medical Tourism will boost India’s economy
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
Granules now have a total of 53 ANDA approvals from USFDA
Subscribe To Our Newsletter & Stay Updated
